FDA Inspection 1017805 — Evangelos J. Giamarellos-Bourboulis, MD, PhD
The FDA completed an inspection of Evangelos J. Giamarellos-Bourboulis, MD, PhD on May 26, 2017 in Athens. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 26, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Athens (Greece)
Additional Details
Clinical Investigator (CI)